These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8092827)

  • 1. Anti-human immunodeficiency virus activities of the beta-L enantiomer of 2',3'-dideoxycytidine and its 5-fluoro derivative in vitro.
    Gosselin G; Schinazi RF; Sommadossi JP; Mathé C; Bergogne MC; Aubertin AM; Kirn A; Imbach JL
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1292-7. PubMed ID: 8092827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
    Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
    J Med Chem; 1994 Mar; 37(6):798-803. PubMed ID: 8145230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro.
    Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
    Biochem Pharmacol; 1994 Jan; 47(2):171-4. PubMed ID: 8304960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human immunodeficiency virus type 1 reverse transcriptase by the 5'-triphosphate beta enantiomers of cytidine analogs.
    Faraj A; Agrofoglio LA; Wakefield JK; McPherson S; Morrow CD; Gosselin G; Mathe C; Imbach JL; Schinazi RF; Sommadossi JP
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2300-5. PubMed ID: 7530932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides.
    Van Draanen NA; Tisdale M; Parry NR; Jansen R; Dornsife RE; Tuttle JV; Averett DR; Koszalka GW
    Antimicrob Agents Chemother; 1994 Apr; 38(4):868-71. PubMed ID: 7518218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.
    Schinazi RF; McMillan A; Cannon D; Mathis R; Lloyd RM; Peck A; Sommadossi JP; St Clair M; Wilson J; Furman PA
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2423-31. PubMed ID: 1283296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of stereoisomerism on the cellular pharmacology of beta-enantiomers of cytidine analogs in Hep-G2 cells.
    Martin LT; Faraj A; Schinazi RF; Gosselin G; Mathe C; Imbach JL; Sommadossi JP
    Biochem Pharmacol; 1997 Jan; 53(1):75-87. PubMed ID: 8960066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious amplification of wild-type human immunodeficiency virus from patients' lymphocytes and modulation by reverse transcriptase inhibitors in vitro.
    Mathez D; Schinazi RF; Liotta DC; Leibowitch J
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2206-11. PubMed ID: 7504908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anti-HIV activity of several 2'-fluoro-containing pyrimidine nucleosides.
    Sterzycki RZ; Ghazzouli I; Brankovan V; Martin JC; Mansuri MM
    J Med Chem; 1990 Aug; 33(8):2150-7. PubMed ID: 2165162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pure nucleoside enantiomers of beta-2',3'-dideoxycytidine analogs are selective inhibitors of hepatitis B virus in vitro.
    Schinazi RF; Gosselin G; Faraj A; Korba BE; Liotta DC; Chu CK; Mathé C; Imbach JL; Sommadossi JP
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2172-4. PubMed ID: 7811039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of drug-resistant variants of human immunodeficiency virus type 1 by in vitro passage in increasing concentrations of 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine.
    Gao Q; Gu Z; Hiscott J; Dionne G; Wainberg MA
    Antimicrob Agents Chemother; 1993 Jan; 37(1):130-3. PubMed ID: 8381634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable interaction of beta-L(-) nucleoside analogues with clinically approved anti-HIV nucleoside analogues for the treatment of human immunodeficiency virus.
    Bridges EG; Dutschman GE; Gullen EA; Cheng YC
    Biochem Pharmacol; 1996 Mar; 51(6):731-6. PubMed ID: 8602867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anti-HIV-1 activity of 2'-"up"-fluoro analogues of active anti-AIDS nucleosides 3'-azido-3'-deoxythymidine (AZT) and 2',3'-dideoxycytidine (DDC).
    Watanabe KA; Harada K; Zeidler J; Matulic-Adamic J; Takahashi K; Ren WY; Cheng LC; Fox JJ; Chou TC; Zhu QY
    J Med Chem; 1990 Aug; 33(8):2145-50. PubMed ID: 1695683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells. Implications for predicting drug hepatotoxicity.
    Cui L; Schinazi RF; Gosselin G; Imbach JL; Chu CK; Rando RF; Revankar GR; Sommadossi JP
    Biochem Pharmacol; 1996 Nov; 52(10):1577-84. PubMed ID: 8937473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidyl-2',3'-dideoxy-3'-thiacytidine: synthesis and antiviral activity in hepatitis B-and HIV-1-infected cells.
    Xie H; Voronkov M; Liotta DC; Korba BA; Schinazi RF; Richman DD; Hostetler KY
    Antiviral Res; 1995 Oct; 28(2):113-20. PubMed ID: 8585765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enantiomeric 2',3'-dideoxycytidine derivatives are potent human immunodeficiency virus inhibitors in cell cultures.
    Gosselin G; Mathé C; Bergogne MC; Aubertin AM; Kirn A; Schinazi RF; Sommadossi JP; Imbach JL
    C R Acad Sci III; 1994 Jan; 317(1):85-9. PubMed ID: 7987696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides.
    Schinazi RF; Lloyd RM; Nguyen MH; Cannon DL; McMillan A; Ilksoy N; Chu CK; Liotta DC; Bazmi HZ; Mellors JW
    Antimicrob Agents Chemother; 1993 Apr; 37(4):875-81. PubMed ID: 7684216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes.
    Schinazi RF; Chu CK; Peck A; McMillan A; Mathis R; Cannon D; Jeong LS; Beach JW; Choi WB; Yeola S
    Antimicrob Agents Chemother; 1992 Mar; 36(3):672-6. PubMed ID: 1320365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus beta-D(+) nucleoside analogs in vitro.
    Dutschman GE; Bridges EG; Liu SH; Gullen E; Guo X; Kukhanova M; Cheng YC
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1799-804. PubMed ID: 9661024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
    Tisdale M; Kemp SD; Parry NR; Larder BA
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5653-6. PubMed ID: 7685907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.